EUVIMEDEUVIMED entdecken
Crossref

The state of the problem of developing combined antibacterial agents relating to bacterial pathogens of critical priority level (review of foreign literature data)

Aleksandr V. Alimov, Ludmila V. Nogovitsyna, Nadezhda V. Cherkashina, Nataliya V. Kolchanova, Roman V. Kotel′nikov, Yulia A. Zakharova

Disinfectology · 10.04.2026 · 2 (1) · 6-14

DOI: 10.47470/dez013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disinfectology, erschienen am 10.04.2026. Verfasst von Aleksandr V. Alimov und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review, based on data from international literature, is devoted to assessing the current state of development of combination antibacterial agents (ABAs) against bacterial pathogens of critical priority. Literature sources were searched in electronic databases such as PubMed, Google Scholar, and SpringerLink.In May 2024, the World Health Organization published an updated “List of Priority Bacterial Pathogens”, which includes 15 families of antibiotic-resistant bacteria divided into groups of critical, high, and medium priority. Bacterial pathogens of critical priority, including gram-negative bacteria resistant to last-resort β-lactam antibiotics, occupy a special place in this list. These include Acinetobacter baumannii, which is resistant to carbapenems, and Enterobacterales, which are resistant to third-generation cephalosporins and carbapenems. Additionally, rifampicin-resistant Mycobacterium tuberculosis is classified as a pathogen of critical priority.It has been established that between May 2017 and December 2023, four combination ABAs were approved by foreign regulatory authorities (cephalosporin Fetroja, carbapenems Vabomere and Recarbrio, and the combination agent Xacduro). Two drugs (Fetroja and Xacduro) are active against carbapenem-resistant A. baumannii; three drugs (Fetroja, Vabomere, and Recarbrio) are active against carbapenem-resistant Enterobacterales. For infections caused by Enterobacterales resistant to third-generation cephalosporins and M. tuberculosis resistant to rifamycins, new combination ABAs have not yet been introduced into clinical practice.Fifteen combination ABAs are currently undergoing clinical trials at various phases (Phase III — six ABAs, Phase II — one ABA, Phase I — eight ABAs). Among the developer countries, the USA is the leader (eight ABAs), followed by Japan (six ABAs). Additional development efforts are underway in China, India, France, Germany, Italy, and Canada.Contribution: Alimov А.V. — edition; Nogovitsyna L.V. — design of the study, data processing, writing the text; Cherkashina N.V. — concept of the study, edition; Kolchanova N.V. — collection of materials, data processing; Kotel′nikov R.V. — collection of materials; Zakharova Yu.A. — edition. All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.Funding source. This study was not supported by any external sources of funding.Conflict of interest. The authors declare no apparent or potential conflicts of interest related to the publication of this article.Received: 10.01.2026 / Accepted: 20.03.2026 / Published: 10.04.2026

Zitieren

APA

Alimov, A. V., Nogovitsyna, L. V., Cherkashina, N. V., Kolchanova, N. V., Kotel′nikov, R. V., & Zakharova, Y. A. (2026). The state of the problem of developing combined antibacterial agents relating to bacterial pathogens of critical priority level (review of foreign literature data). Disinfectology, 2(1), 6-14. https://doi.org/10.47470/dez013

Vancouver

Alimov AV, Nogovitsyna LV, Cherkashina NV, Kolchanova NV, Kotel′nikov RV, Zakharova YA. The state of the problem of developing combined antibacterial agents relating to bacterial pathogens of critical priority level (review of foreign literature data). Disinfectology. 2026;2(1):6-14. doi:10.47470/dez013

BibTeX
@article{Alimov2026,
  author = {Alimov, Aleksandr V. and Nogovitsyna, Ludmila V. and Cherkashina, Nadezhda V. and Kolchanova, Nataliya V. and Kotel′nikov, Roman V. and Zakharova, Yulia A.},
  title = {The state of the problem of developing combined antibacterial agents relating to bacterial pathogens of critical priority level (review of foreign literature data)},
  journal = {Disinfectology},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {6--14},
  doi = {10.47470/dez013}
}
Kostenlos starten →